| mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.9 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.9 |
| mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.01 |
0.9 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.9 |
| mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |